Seikagaku Corp

4548

Company Profile

  • Business description

    Seikagaku Corp makes and sells pharmaceuticals and medical devices related to glycoconjugates. The firm operates in two segments: pharmaceutical and LAL. The pharmaceutical segment contributes the majority of revenue. This business sells pharmaceutical products made from hyaluronic acid, a major component of glycoconjugates, as well as medical devices and bulk products. The LAL segment manufactures endotoxin-detecting reagents made from limulus amebocyte lysate that are used to control quality in the pharmaceutical manufacturing process. Seikagaku generates the majority of its sales in Japan.

  • Contact

    Marunouchi Center Building 10 Floor
    6-1, Marunouchi 1-chome, Chiyoda-ku
    Tokyo100-0005
    JPN

    T: +81 352208950

    http://www.seikagaku.co.jp

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 March 2027

    Employees

    1,183

Stocks News & Analysis

stocks

Investors cheer Guzman dialing back global ambitions

Our view after US restaurants are closed.
stocks

Why stocks sometimes fall for no obvious reason

How the private markets impact all equity investors.
stocks

Poor organic growth obscured by acquisition for ASX listed share

Sales dropped by 2% without impact of acquisition.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,882.6020.50-0.23%
CAC 408,173.1185.15-1.03%
DAX 4025,184.89204.21-0.80%
Dow JONES (US)50,461.68118.02-0.23%
FTSE 10010,491.3925.130.24%
HKSE25,599.456.58-0.03%
NASDAQ26,656.18312.211.19%
Nikkei 22564,996.09162.10-0.25%
NZX 50 Index13,069.7499.460.77%
S&P 5007,519.1245.650.61%
S&P/ASX 2008,657.8018.80-0.22%
SSE Composite Index4,145.377.20-0.17%

Market Movers